The management of breast cancer (BC), the most common tumor in women [1] has improved since its sub-classification based on the expression of estrogen (ER), progesterone receptors (PR) [2] and human epidermal growth factor receptor-2 (HER2) [3]. This evidence concerns the gene ESR1 and breast cancer.